Fresenius Medical Care (NYSE:FMS) Shares Gap Up – Time to Buy?

Fresenius Medical Care AG (NYSE:FMS) shares gapped up prior to trading on Friday . The stock had previously closed at $21.32, but opened at $21.93. Fresenius Medical Care shares last traded at $21.90, with a volume of 52,465 shares trading hands.

Analysts Set New Price Targets

A number of analysts recently commented on the company. StockNews.com assumed coverage on Fresenius Medical Care in a research report on Saturday, November 9th. They issued a “strong-buy” rating for the company. Berenberg Bank began coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price objective for the company. Finally, Truist Financial upped their target price on Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Fresenius Medical Care Stock Up 3.6 %

The company has a market cap of $12.96 billion, a price-to-earnings ratio of 18.10, a price-to-earnings-growth ratio of 0.97 and a beta of 0.91. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The stock’s fifty day moving average is $20.60 and its two-hundred day moving average is $20.24.

Institutional Investors Weigh In On Fresenius Medical Care

Institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC boosted its holdings in Fresenius Medical Care by 50.0% during the 1st quarter. SG Americas Securities LLC now owns 15,228 shares of the company’s stock worth $294,000 after acquiring an additional 5,078 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in Fresenius Medical Care by 19.5% during the first quarter. QRG Capital Management Inc. now owns 54,363 shares of the company’s stock worth $1,048,000 after purchasing an additional 8,870 shares during the last quarter. SageView Advisory Group LLC purchased a new position in Fresenius Medical Care during the first quarter worth about $127,000. Signaturefd LLC grew its position in Fresenius Medical Care by 8.4% in the 2nd quarter. Signaturefd LLC now owns 8,713 shares of the company’s stock worth $166,000 after purchasing an additional 672 shares in the last quarter. Finally, Ritholtz Wealth Management increased its stake in Fresenius Medical Care by 2.5% in the 2nd quarter. Ritholtz Wealth Management now owns 36,901 shares of the company’s stock valued at $704,000 after buying an additional 895 shares during the last quarter. Institutional investors own 8.25% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.